L-DOPA and Serotonergic Neurons: Functional Implication and Therapeutic Perspectives in Parkinson's Disease

E-ISSN： 1875-6166|11|4|305-320

ISSN： 1871-5249

Source： Central Nervous System Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Central Nervous System Agents), Vol.11, Iss.4, 2011-12, pp. : 305-320

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Animal models of Parkinson’s disease and L-dopa induced dyskinesia: How close are we to the clinic?

By Lane Emma Dunnett Stephen

Psychopharmacology, Vol. 199, Iss. 3, 2008-08 ,pp. : 303-312

Springer Publishing Company

Access to resources Recommend Favorite

Role of Catechol-O-Methyltransferase (COMT)-Dependent Processes in Parkinson’s Disease and L-DOPA Treatment

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 11, Iss. 3, 2012-05 ,pp. : 251-263

Bentham Science Publishers

Access to resources Recommend Favorite

Receptor Heteromers in Parkinson’s Disease and L-DOPA-Induced Dyskinesia

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 12, Iss. 8, 2013-12 ,pp. : 1101-1113

Bentham Science Publishers

Access to resources Recommend Favorite

Corrigendum Monitoring of L -DOPA Concentrations in Parkinson's Disease10.1006/phrs.2001.0819

Pharmacological Research, Vol. 44, Iss. 2, 2001-08 ,pp. : 149-149

Academic Press

Access to resources Recommend Favorite

Implication of Green Tea as a Possible Therapeutic Approach for Parkinson Disease

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 15, Iss. 3, 2016-04 ,pp. : 292-300

Bentham Science Publishers

Access to resources Recommend Favorite